Search Results

from there. So I limped in to see the doctor he recommended. She did a very thorough job of poking around my knee, made a clinical diagnosis, and recommended an MRI. I had the temerity to ask why she was a noninterventional orthopedist since I assumed

metastases—a Gynecologic Oncology Group study . Gynecol Oncol 1990 ; 38 : 425 – 430 . 6. Kim SH Choi BI Han JK . Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients . J Comput Assist Tomogr 1993 ; 17

of ≥100. Finally the “M” stands for MRI: patients with focal bone marrow deposits of MM >0.5 cm found on MRI should be classified as symptomatic MM and therapy should be initiated. “So any one of those 3 features, even if a person is completely well

baseline (CT or MRI) and then approximately every 2 cycles (or every 8 weeks [± 1 week]). After 10 months, imaging will be performed approximately every 3 cycles (or every 12 weeks [± 1 week]). Patients may remain in the study until disease progression or

biomarkers along with clinical factors, including findings on DRE. 17 Multiparametric MRI and MRI-guided prostate biopsy have become integral components of patient evaluation at many institutions. 18 , 19 Multiparametric MRI can be used to confirm low

, but because all lesions did not fully equilibrate, a subsequent abdominal ultrasound was performed and revealed multiple hypoechoic solid lesions, believed to be inconsistent with hemangiomas. An MRI of the abdomen showed numerous liver lesions of low

fibroid. Pelvic MRI showed a 10-cm left adnexal mass with a polylobed aspect, associated with a cystic portion that had a mucinous borderline epithelial part. The patient's CA 125 level was 237 UI/mL and carcinoembryonic antigen level was 37.6 ng/mL. The

participating in a clinical trial to identify novel screening approaches for these patients. This screening program consists of whole-body MRI (including dedicated brain MRI), skin examination, urine cytology annually, and comprehensive laboratory studies

imaging may include diagnostic mammography, ultrasonography, and at times diagnostic breast MRI. The eventual decision regarding need for tissue sampling is based on level of suspicion on imaging and/or clinical examination. Biopsy is needed in situations

details about tumor size and contiguity to nearby visceral structures and neurovascular landmarks. The panel recommends MRI with contrast, with or without CT with contrast. Other imaging studies such as CT angiogram and plain radiograph may be warranted in